Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Ozdemir · SciRah

Researcher profile · Semantic Scholar

V. Ozdemir

Share profile

V. Ozdemir — researcher profile on SciRah

h-index: 27
Works: 98
Citations: 2,338

Most-cited papers

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.
V. Ozdemir, W. Kalow, B. Tang, Andrew D. Paterson +3 more
2000Pharmacogenetics (London)416 citations
Semantic Scholar
Shifting emphasis from pharmacogenomics to theragnostics
V. Ozdemir, B. Williams-Jones, S. Glatt, M. Tsuang +2 more
2006Nature Biotechnology128 citations Open access
Semantic Scholar
Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin.
Qing Li, Bi-Lian Chen, V. Ozdemir, Wei Ji +7 more
2007Pharmacogenomics (London)79 citations
Semantic Scholar
Second-Generation Antipsychotic Exposure and Metabolic-Related Disorders in Patients With Schizophrenia: An Observational Pharmacoepidemiology Study From 1988 to 2002
C. Reist, J. Mintz, L. Albers, M. Jamal +2 more
2007Journal of Clinical Psychopharmacology78 citations
Semantic Scholar
Novelty seeking and the dopamine D4 receptor gene (DRD4) revisited in Asians: Haplotype characterization and relevance of the 2‐repeat allele
C. Reist, V. Ozdemir, Eric T. Wang, M. Hashemzadeh +2 more
2007American Journal of Medical Genetics Part B: Neuropsychiatric Genetics76 citations
Semantic Scholar
SLCO1B1 521T-->C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients.
Wei Zhang, Bi-Lian Chen, V. Ozdemir, Yi-Jing He +10 more
2007British Journal of Clinical Pharmacology74 citations Open access
Semantic Scholar
Risk Assessment and Communication Tools for Genotype Associations with Multifactorial Phenotypes: The Concept of “Edge Effect” and Cultivating an Ethical Bridge between Omics Innovations and Society
V. Ozdemir, G. Suarez-Kurtz, R. Stenne, Andrew A. Somogyi +3 more
2009Omics57 citations Open access
Semantic Scholar
The United States of America and Scientific Research
G. Hather, Winston A. Haynes, R. Higdon, Natali Kolker +12 more
2010PLoS ONE50 citations Open access
Semantic Scholar
Personalized Medicine Beyond Genomics: New Technologies, Global Health Diplomacy and Anticipatory Governance.
V. Ozdemir, D. Husereau, S. Hyland, S. Samper +1 more
2009Current Pharmacogenomics and Personalized Medicine43 citations Open access
Semantic Scholar
Pharmacogenomic-guided rational therapeutic drug monitoring: conceptual framework and application platforms for atypical antipsychotics.
L. Albers, V. Ozdemir
2004Current Medicinal Chemistry43 citations
Semantic Scholar
Mapping translational research in personalized therapeutics: from molecular markers to health policy.
V. Ozdemir, B. Williams-Jones, Dan M. Cooper, T. Someya +1 more
2007Pharmacogenomics (London)40 citations Open access
Semantic Scholar
Standardization and Omics Science: Technical and Social Dimensions Are Inseparable and Demand Symmetrical Study
Christina Holmes, Fiona McDonald, Mavis Jones, V. Ozdemir +1 more
2010Omics39 citations Open access
Semantic Scholar
The science of pharmacological variability: An essay
W. Kalow, V. Ozdemir, B. Tang, L. Tothfalusi +1 more
1999Clinical pharmacology and therapy39 citations
Semantic Scholar
CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine
E. Aklillu, W. Kalow, L. Endrenyi, P. Harper +2 more
2007Pharmacogenetics & Genomics38 citations
Semantic Scholar
CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6–serotonin–dopamine crosstalk revisited
V. Ozdemir, L. Bertilsson, J. Miura, E. Carpenter +8 more
2007Pharmacogenetics & Genomics38 citations
Semantic Scholar
What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?
V. Ozdemir, N. Shear, W. Kalow
2001Drug Safety38 citations
Semantic Scholar
Cosegregation of Gastrointestinal Ulcers and Schizophrenia in a Large National Inpatient Discharge Database
V. Ozdemir, M. Jamal, K. Ősapay, M. Jadus +3 more
2007Journal of Investigative Medicine37 citations
Semantic Scholar
Effect of venlafaxine on imipramine metabolism.
L. Albers, C. Reist, R. Vu, K. Fujimoto +4 more
2000Psychiatry Research36 citations
Semantic Scholar
Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines
V. Ozdemir, E. Aklillu, S. Mee, L. Bertilsson +5 more
2006Expert Opinion on Pharmacotherapy35 citations
Semantic Scholar
Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression
E. Aklillu, S. Karlsson, O. Zachrisson, V. Ozdemir +1 more
2009Pharmacogenetics & Genomics34 citations
Semantic Scholar
CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
V. Ozdemir, W. Kalow, P. Posner, E. Collins +7 more
2001Journal of Clinical Psychopharmacology33 citations
Semantic Scholar
Ethnocultural community leaders’ views and perceptions on biobanks and population specific genomic research: a qualitative research study
B. Godard, V. Ozdemir, Marilyn Fortin, Nathalie Égalité
2010Public Understanding of Science31 citations
Semantic Scholar
Opportunities and Challenges for the Life Sciences Community
E. Kolker, Elizabeth Stewart, V. Ozdemir
2012Omics30 citations Open access
Semantic Scholar
The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline.
V. Ozdemir, C. Naranjo, N. Herrmann, R. Shulman +3 more
1998Journal of Clinical Psychopharmacology30 citations
Semantic Scholar
Treatment of alcohol withdrawal syndrome.
V. Ozdemir, Karen E. Bremner, C. A. Naranjo
1994Annals medicus30 citations
Semantic Scholar
Multigenic control of drug response and regulatory decision-making in pharmacogenomics: The need for an upper-bound estimate of genetic contributions
V. Ozdemir, W. Kalow, L. Tothfalusi, L. Bertilsson +2 more
200529 citations
Semantic Scholar
Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo.
V. Ozdemir, Claudio A. Naranjo, R. Shulman, N. Herrmann +3 more
1998Journal of Clinical Psychopharmacology29 citations
Semantic Scholar
Steering Vaccinomics Innovations with Anticipatory Governance and Participatory Foresight
V. Ozdemir, Samer Faraj, B. Knoppers
2011Omics27 citations
Semantic Scholar
CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype–phenotype association study design in translational pharmacogenetics
Yutaro Suzuki, T. Sugai, N. Fukui, Junzo Watanabe +4 more
2011Journal of Psychopharmacology26 citations
Semantic Scholar
Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.
P. J. Reddy, R. Jain, Y. Paik, R. Downey +3 more
2011Current Pharmacogenomics and Personalized Medicine26 citations Open access
Semantic Scholar
Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health
Catherine Olivier, B. Williams-Jones, B. Godard, Barbara Mikalson +1 more
200824 citations
Semantic Scholar
Aripiprazole (Otsuka Pharmaceutical Co).
V. Ozdemir, J. Fourie, F. Ozdener
2002Current opinion in investigational drugs24 citations
Semantic Scholar
Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA)
V. Ozdemir, D. Rosenblatt, L. Warnich, Sanjeev Srivastava +15 more
2011Current Pharmacogenomics and Personalized Medicine23 citations Open access
Semantic Scholar
Pharmacogenomics research involving racial classification: qualitative research findings on researchers' views, perceptions and attitudes towards socioethical responsibilities.
Nathalie Égalité, V. Ozdemir, B. Godard
2007Pharmacogenomics (London)23 citations
Semantic Scholar
Containing Global Antibiotic Resistance: Ethical Drug Promotion in the Developing World
Catherine Olivier, B. Williams-Jones, B. Doizé, V. Ozdemir
201022 citations
Semantic Scholar
Survival Rate and Causes of Mortality in the Elderly with Depression
Tsuyoshi Kawamura, T. Shioiri, Kuniaki Takahashi, V. Ozdemir +1 more
2007Journal of Investigative Medicine22 citations
Semantic Scholar
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.
V. Ozdemir, Erik Fisher, E. Dove, H. Burton +3 more
2012Current Pharmacogenomics and Personalized Medicine21 citations Open access
Semantic Scholar
Low-Dose Fluvoxamine as an Adjunct to Reduce Olanzapine Therapeutic Dose Requirements: A Prospective Dose-Adjusted Drug Interaction Strategy
L. Albers, V. Ozdemir, S. Marder, M. Raggi +3 more
2005Journal of Clinical Psychopharmacology21 citations
Semantic Scholar
Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.
V. Ozdemir, D. Muljono, T. Pang, L. Ferguson +7 more
2011Current Pharmacogenomics and Personalized Medicine20 citations Open access
Semantic Scholar
Concentration-Response Relationship for Fluvoxamine Using Remission as an Endpoint: A Receiver Operating Characteristics Curve Analysis in Major Depression
Yutaro Suzuki, N. Fukui, K. Sawamura, T. Sugai +5 more
2008Journal of Clinical Psychopharmacology20 citations
Semantic Scholar
Challenges for Corporate Ethics in Marketing Genetic Tests
B. Williams-Jones, V. Ozdemir
200720 citations
Semantic Scholar
Genome–Environment Interactions and Prospective Technology Assessment: Evolution from Pharmacogenomics to Nutrigenomics and Ecogenomics
V. Ozdemir, A. Motulsky, E. Kolker, B. Godard
2009Omics19 citations Open access
Semantic Scholar
Integrating Anticipated Nutrigenomics Bioscience Applications with Ethical Aspects
Lise Lévesque, V. Ozdemir, B. Gremmen, B. Godard
2008Omics19 citations Open access
Semantic Scholar
Evidence-based management of nutrigenomics expectations and ELSIs.
V. Ozdemir, B. Godard
2007Pharmacogenomics (London)19 citations
Semantic Scholar
All the post-genomic world is a stage: the actors and narrators required for translating pharmacogenomics into public health.
E. Dove, V. Ozdemir
2013Personalized Medicine18 citations Open access
Semantic Scholar
What To Do When the Risk Environment Is Rapidly Shifting and Heterogeneous? Anticipatory Governance and Real-Time Assessment of Social Risks in Multiply Marginalized Populations Can Prevent IRB Mission Creep, Ethical Inflation or Underestimation of Risks
V. Ozdemir
2009American Journal of Bioethics17 citations
Semantic Scholar
Hypoglycaemia induced by second generation antipsychotic agents in schizophrenic non-diabetic patients
Yutaro Suzuki, Junzo Watanabe, N. Fukui, V. Ozdemir +1 more
2009British medical journal17 citations
Semantic Scholar
The positive effect of black seed (Nigella sativa L.) essential oil on thyroid hormones in rats with hypothyroidism and hyperthyroidism.
G. Avcı, E. Ulutaş, V. Ozdemir, İ. Kıvrak +1 more
2021Journal of food biochemistry16 citations Open access
Semantic Scholar
Could endogenous substrates of drug-metabolizing enzymes influence constitutive physiology and drug target responsiveness?
V. Ozdemir, A. Gunes, M. Dahl, M. Scordo +2 more
2006Pharmacogenomics (London)16 citations
Semantic Scholar
Anatomical evaluation and stress distribution of intact canine femur
O. Verim, S. Tasgetiren, M. S. Er, V. Ozdemir +1 more
2013The international journal of medical robotics + computer assisted surgery : MRCAS14 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

W. Kalow×8
Invite
W. Kalow — researcher profile on SciRah
C. Reist×8
Invite
C. Reist — researcher profile on SciRah
T. Someya×8
Invite
T. Someya — researcher profile on SciRah
L. Albers×7
Invite
L. Albers — researcher profile on SciRah

×7

Invite

B. Godard — researcher profile on SciRah

Invite

L. Endrenyi — researcher profile on SciRah

B. Williams-Jones×6

Invite

B. Williams-Jones — researcher profile on SciRah

Invite

E. Kolker — researcher profile on SciRah

Invite

B. Tang — researcher profile on SciRah

Invite

J. Graham — researcher profile on SciRah

Invite

E. Aklillu — researcher profile on SciRah

L. Bertilsson×3

Invite

L. Bertilsson — researcher profile on SciRah